They observed overlapping patterns of inflammation and keratinocyte activity between Blaschko linear psoriasis and psoriasis vulgaris but also detected notable differences, particularly in pathways related to IL-4, IL-13, and IL-36 signaling. The gene discussed is IL13; the disease is psoriasis vulgaris.